首页 正文

Targeting pheochromocytoma/paraganglioma with polyamine inhibitors

{{output}}
Background: Pheochromocytomas (PCCs) and paragangliomas (PGLs) are neuroendocrine tumors that are mostly benign. Metastatic disease does occur in about 10% of cases of PCC and up to 25% of PGL, and for these patients no effective... ...